Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.22.1
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Adjusted balance
Common Stock warrants
Common Stock
Common Stock
Adjusted balance
Common Stock
Common Stock warrants
Additional Paid-in Capital
Additional Paid-in Capital
Adjusted balance
Additional Paid-in Capital
Common Stock warrants
Other Comprehensive Income
Other Comprehensive Income
Adjusted balance
Accumulated Deficit
Accumulated Deficit
Adjusted balance
Balance at beginning of period at Dec. 31, 2020   $ (32,813)     $ 3     $ 191,168     $ 0   $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020         34,692                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation $ 508           $ 508            
Issuance of common stock upon exercise of stock options 1           1            
Issuance of common stock upon exercise of stock options (in shares)       468                  
Issuance of common stock upon vesting of restricted stock awards (in shares)       171                  
Other comprehensive income 1,389                 $ 1,389      
Net loss (168,556)                     $ (168,556)  
Balance at end of period at Mar. 31, 2021 (95,627)     $ 5     295,519     1,389   (392,540)  
Balance at end of period (in shares) at Mar. 31, 2021       56,455                  
Balance at beginning of period at Dec. 31, 2021 $ 179,620     $ 11     650,518     0   (470,909)  
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452     114,452                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation $ 10,862           10,862            
Issuance of common stock due to Bridge Notes 103,724     $ 2     103,722            
Issuance of common stock due to Bridge Notes (in shares)       20,029                  
Issuance of common stock upon exercise of stock options $ 17           17            
Issuance of common stock upon exercise of stock options (in shares) 404     404                  
Issuance of common stock upon vesting of restricted stock awards (in shares)       129                  
Issuance of common stock upon vesting of restricted stock units $ 1     $ 1                  
Issuance of common stock upon vesting of restricted stock units (in shares)       4,816                  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)       (1,874)                  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (3,616)           (3,616)            
Issuance of common stock on conversion (in shares)           1,095              
Issuance of common stock on conversion     $ 120           $ 120        
Other comprehensive income 0                        
Net loss (19,988)                     (19,988)  
Balance at end of period at Mar. 31, 2022 $ 166,896     $ 12     $ 657,781     $ 0   $ (490,897)  
Balance at end of period (in shares) at Mar. 31, 2022 117,927     117,927